Evaluation of Satisfaction and Short-term Side effect after OsteoCalVitFort Practice

Evaluation of Satisfaction and Short-term Side effect after OsteoCalVitFort Practice in population whom use Calcium Supplement

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT201312031414N30

Enrollment

200

Registered

2014-02-24

Start date

2013-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

side effect of Calcium vitamin D.

Interventions

phase 4, single arm , one-month study, after entering care, 2 times OsteoCalVit Fort use for one month..

phase 4, single arm , one-month study, after entering care, 2 times OsteoCalVit Fort use for one month.

Eligibility

Sex/Gender

All

Age

45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 45 to 70 years old who received Calcium supplement; In good health, as determined by the principal investigator based on medical history and physical examination; Clinical laboratory evaluations within the reference range for the test laboratory; Ability to comprehend and willingness to sign the Informed Consent Form for this study. Exclusion criteria: Clinically complicated biochemical tests; Any diagnosed malignancy; Any drug hypersensitivity; History of kidney stone; hyperparathyroidism or sarcoidosis; unwilling to participation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Side Effects. Timepoint: befor intervention and 1 month after intervention. Method of measurement: Questionnarie.	—

Secondary

Measure	Time frame
Satisfaction. Timepoint: 1 month Aftere the intervention. Method of measurement: Qusetionnarie.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026